{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:39:43Z","timestamp":1791311983491,"version":"4.3.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T00:00:00Z","timestamp":1370304000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0065037","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T21:25:56Z","timestamp":1370381156000},"page":"e65037","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":75,"title":["Adverse Reactions Due to Directly Observed Treatment Strategy Therapy in Chinese Tuberculosis Patients: A Prospective Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Xiaozhen","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,6,4]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2012) Global Tuberculosis Report 2012: The burden of disease caused by TB. Geneva, Switzerland. 10\u201317 p."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/1471-2458-10-267","article-title":"Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS)","volume":"10","author":"YY Xia","year":"2010","journal-title":"BMC Public Health"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)16764-0","article-title":"The effect of tuberculosis control in China","volume":"364","author":"Collaboration China Tuberculosis Control","year":"2004","journal-title":"Lancet"},{"key":"ref4","unstructured":"World Health Organization (2002) An expanded DOTS framework for effective tuberculosis control. Stop TB Communicable Diseases. Geneva: WHO Press. 1\u201320 p."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"D Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","first-page":"134","article-title":"Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients","volume":"4","author":"K Gholami","year":"2006","journal-title":"Pharm Prac"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/pds.1468","article-title":"Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors","volume":"16","author":"MR Javadi","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0962-8479(96)90073-8","article-title":"Frequency and type of reactions to antituberculosis drugs: observations in routine treatment","volume":"77","author":"LP Ormerod","year":"1996","journal-title":"Tubercle and Lung Disease"},{"key":"ref9","first-page":"626","article-title":"Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs","volume":"36","author":"MA Arbex","year":"2010","journal-title":"J Bras Pneumol"},{"key":"ref10","first-page":"1049","article-title":"Adverse effects of tuberculosis treatment: experience at an outpatient clinic of a teaching hospital in the city of S\u00e3o Paulo, Brazil","volume":"34","author":"DE Vieira","year":"2008","journal-title":"J Bras Pneumol"},{"key":"ref11","first-page":"185","article-title":"Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients","volume":"21","author":"Z Zaka-Ur-Rehman","year":"2008","journal-title":"Pak J Pharm Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.rmed.2006.01.014","article-title":"Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis","volume":"100","author":"BE G\u00fclbay","year":"2006","journal-title":"Respir Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1183\/09031936.96.09102026","article-title":"Risk factors for side-effects of isoniazid, Damrifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis","volume":"9","author":"T Schaberg","year":"1996","journal-title":"Eur Respir J"},{"key":"ref14","first-page":"868","article-title":"Adverse drug reactions associated with first-line anti-tuberculosis drug regimens","volume":"11","author":"F Marra","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref15","first-page":"531","article-title":"Study of adverse drug reactions caused by first line anti-tubercular drugs used in directly observed treatment, short course (DOTS) therapy in Western Nepal, Pokhara","volume":"58","author":"AK Chhetri","year":"2008","journal-title":"J Pak Med Assoc"},{"key":"ref16","first-page":"251","article-title":"Adverse drug reactions observed during DOTS","volume":"36","author":"VK Dhingra","year":"2004","journal-title":"J Commun Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.1840210407","article-title":"Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subful-minant liver failure during antituberculous treatment including isoniazid","volume":"21","author":"F Durand","year":"1995","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Awofeso N (2008) Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ 86: B\u2013D.","DOI":"10.2471\/BLT.07.043802"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2458-4-68","article-title":"An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment","volume":"4","author":"FA Kaona","year":"2004","journal-title":"BMC Public Health"},{"key":"ref20","first-page":"232","article-title":"Adverse effects of the new tuberculosis treatment regimen recommended by the Brazilian Ministry of Health","volume":"36","author":"EL Maciel","year":"2010","journal-title":"J Bras Pneumol"},{"key":"ref21","first-page":"419","article-title":"Systematic review of anti-tuberculosis drug induced Adverse reactions in China","volume":"30","author":"YY Xia","year":"2007","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"IR Edwards","year":"2000","journal-title":"Lancet"},{"key":"ref23","unstructured":"The UPPSALA MONITORING CENTRE: The use of the WHO-UMC system for standardized case causality assessment. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/who-umc.org\/Graphics\/24734.pdf\" xlink:type=\"simple\">http:\/\/who-umc.org\/Graphics\/24734.pdf<\/ext-link>. Accessed 2012 March 5."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e21836","DOI":"10.1371\/journal.pone.0021836","article-title":"Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China","volume":"7","author":"P Shang","year":"2011","journal-title":"PLoS ONE"},{"key":"ref25","unstructured":"World Health Organization (2009) Treatment of Tuberculosis: Guidelines-4th ed. Geneva, Switzerland: 58 p."},{"key":"ref26","unstructured":"China Public Health Science Database Center (2008) Report of tuberculosis monitoring in 2008: the distribution of gender and age in new smear positive patients."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00228-008-0484-8","article-title":"Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil","volume":"64","author":"LG Possuelo","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/qshc.2004.010611","article-title":"Adverse drug events and medication errors: detection and classification methods","volume":"Care13","author":"T Morimoto","year":"2004","journal-title":"Qual Saf Health"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0041-3879(82)80018-4","article-title":"Adverse effects of antituberculosis drugs causing changes in treatment","volume":"63","author":"LJ Gonzalez Montaner","year":"1982","journal-title":"Tubercle"},{"key":"ref30","first-page":"382","article-title":"Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding","volume":"14","author":"JA Caminero","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref31","unstructured":"WHO (2007) Tuberculosis fact sheets. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/<\/ext-link>. Accessed 2012 May 17."},{"key":"ref32","unstructured":"World Health Organization (2012) Global Tuberculosis Report 2012: TB case notifications and treatment outcomes. Geneva, Switzerland. 40 p."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199512010-00001","article-title":"Avoidance and Management of Adverse Reactions to Antituberculosis Drugs","volume":"12","author":"AM Patel","year":"1995","journal-title":"Drug Safety"},{"key":"ref34","unstructured":"Tu DH, Chen MT (2011) Adverse reactions reporting and monitoring. In Anti-tuberculosis Drugs Management Manual. Wang LX and Chen MT (eds). People\u2019s Military Medical Press: Beijing, 68\u201372 p."},{"key":"ref35","unstructured":"China AIDS epidemic 2011. The Ministry of Health of the People\u2019s Republic of China. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/download.chinagate.cn\/ch\/pdf\/aizibing.pdf\" xlink:type=\"simple\">http:\/\/download.chinagate.cn\/ch\/pdf\/aizibing.pdf<\/ext-link>. Accessed 2012 Nov 20."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0065037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:39:33Z","timestamp":1588984773000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0065037"}},"subtitle":[],"editor":[{"given":"Robert J.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,4]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0065037","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,4]]}}}